Amgen, Horizon Say FTC Constitutionality Key To Merger Row

By Bryan Koenig · August 11, 2023, 8:01 PM EDT

Amgen and Horizon Therapeutics urged an Illinois federal judge Thursday to preserve their attacks on the constitutionality of the Federal Trade Commission and its in-house process as part of the agency...

To view the full article, register now.

Documents

Case Information

Case Title

Federal Trade Commission V. Amgen Inc., et al.

Case Number

1:23-cv-03053

Court

Illinois Northern

Nature of Suit

410(Anti-Trust)

Date Filed

May 16, 2023